<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05006183</url>
  </required_header>
  <id_info>
    <org_study_id>SP0001</org_study_id>
    <nct_id>NCT05006183</nct_id>
  </id_info>
  <brief_title>Instantaneous Wave-free Ratio Guidance Strategy Evaluation in the Treatment of Multivessel Acute Coronary Syndrome.</brief_title>
  <acronym>iStrategy</acronym>
  <official_title>Characterization of Coronary Artery Hemodynamic Measurements and Virtual Angioplasty Planning by Instantaneous Wave-free Ratio (iFR) in Multivessel Acute Coronary Syndrome Patients With Evaluation of the Impact on Clinical Outcomes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Daugavpils Regional Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Riga Stradins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Daugavpils Regional Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single-center, prospective, randomized, open-label, blinded end-point clinical trial of&#xD;
      instantaneous wave-free ratio (iFR) guidance strategy impact on clinical outcomes in&#xD;
      multivessel acute coronary syndrome (ACS) patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The &quot;all-comers&quot; study population consists of hemodynamically stable de novo ACS patients&#xD;
      with a stenosis of 50% and more by visual estimation in at least two separate coronary&#xD;
      arteries with Thrombolysis in Myocardial Infarction (TIMI) flow ≥ 2 and willing to sign a&#xD;
      patient informed consent. ACS diagnosis established by angina pectoris symptoms and/or ECG&#xD;
      changes and/or hs-troponin I levels. The use of drug-eluting stents is mandatory in both&#xD;
      treatment groups. In the intervention strategy group, patients are treated by the iFR-guided&#xD;
      percutaneous coronary intervention (PCI) in one stage. In the control group, patients are&#xD;
      treated in accordance with the standard practice of angiography-guided staged approach.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 8, 2019</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PCI-related Major adverse cardiac events (MACE)</measure>
    <time_frame>Index admission</time_frame>
    <description>Composite of cardiac death, non-fatal myocardial infarction, unplanned revascularization, stent thrombosis, flow limiting coronary dissections, no-reflow phenomenon, coronary perforations, coronary distal embolization, vascular access site complications requiring blood transfusion or surgical intervention and acute renal failure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PCI-related Major adverse cardiac events (MACE)</measure>
    <time_frame>3 months</time_frame>
    <description>Composite of cardiac death, non-fatal myocardial infarction, unplanned revascularization, stent thrombosis, flow limiting coronary dissections, no-reflow phenomenon, coronary perforations, coronary distal embolization, vascular access site complications requiring blood transfusion or surgical intervention and acute renal failure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PCI-related Major adverse cardiac events (MACE)</measure>
    <time_frame>12 months</time_frame>
    <description>Composite of cardiac death, non-fatal myocardial infarction, unplanned revascularization, stent thrombosis, flow limiting coronary dissections, no-reflow phenomenon, coronary perforations, coronary distal embolization, vascular access site complications requiring blood transfusion or surgical intervention and acute renal failure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Segmental myocardial deformation by speckle-tracking echocardiography</measure>
    <time_frame>Index admission, 3 months and 12 months</time_frame>
    <description>Change of segmental myocardial deformation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of Life</measure>
    <time_frame>Index admission, 3 months and 12 months</time_frame>
    <description>Change in health-related quality of life measured using the EQ-5D-5L questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Cardiac Ischemia</condition>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>iFR-guided</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One-stage, virtually planned, iFR-guided and optimized PCI.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Angiography-guided</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard practice staged angiography-guided PCI</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PCI</intervention_name>
    <description>Percutaneous coronary intervention with Drug-Eluting Stents</description>
    <arm_group_label>Angiography-guided</arm_group_label>
    <arm_group_label>iFR-guided</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age and older&#xD;
&#xD;
          -  willing to give informed consent&#xD;
&#xD;
          -  hemodynamically stable de novo acute coronary syndrome patients with a stenosis of 50%&#xD;
             and more by visual estimation in at least two separate coronary arteries&#xD;
&#xD;
          -  adequate coronary flow, Thrombolysis in Myocardial Infarction (TIMI) flow ≥ 2&#xD;
&#xD;
          -  sinus rhythm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  inability to give consent;&#xD;
&#xD;
          -  younger than 18 years of age&#xD;
&#xD;
          -  atrial fibrillation rhythm at the time of inclusion&#xD;
&#xD;
          -  with significant valve disease&#xD;
&#xD;
          -  in cardiogenic shock&#xD;
&#xD;
          -  with reduced kidney function - eGFR &lt; 30 (mL/min/1.73m2);&#xD;
&#xD;
          -  with congenital heart defects&#xD;
&#xD;
          -  with acute pulmonary artery embolism;&#xD;
&#xD;
          -  with isolated left main ostial stenosis;&#xD;
&#xD;
          -  on active oncologic treatment or toxic cardiomyopathy;&#xD;
&#xD;
          -  revascularization by PCI is not possible due to other comorbidities or patient denial&#xD;
             of treatment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Deniss Vasiljevs, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Daugavpils Regional Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Deniss Vasiljevs, MD</last_name>
    <phone>+37165440858</phone>
    <email>d.vasiljevs@siadrs.lv</email>
  </overall_contact>
  <location>
    <facility>
      <name>Daugavpils Regional Hospital</name>
      <address>
        <city>Daugavpils</city>
        <zip>LV-5417</zip>
        <country>Latvia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deniss Vasiljevs, MD</last_name>
      <phone>+37165440858</phone>
      <email>d.vasiljevs@siadrs.lv</email>
    </contact>
  </location>
  <location_countries>
    <country>Latvia</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 2, 2021</study_first_submitted>
  <study_first_submitted_qc>August 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2021</study_first_posted>
  <last_update_submitted>August 7, 2021</last_update_submitted>
  <last_update_submitted_qc>August 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Daugavpils Regional Hospital</investigator_affiliation>
    <investigator_full_name>Deniss Vasiljevs</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>iFR</keyword>
  <keyword>Instantaneous wave free ratio</keyword>
  <keyword>virtual percutaneous coronary intervention</keyword>
  <keyword>Acute coronary syndrome</keyword>
  <keyword>Multivessel</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

